User name
Password

Don't have a user name yet?
Register here.

Help

Krka Investigated for Suspected Anti-Trust Deal

Brussels, 8 July - The European Commission announced on Wednesday that it had launched formal proceedings against Slovenian drug maker Krka and several other generic pharma companies as part of an anti-trust probe at French Les Laboratoires Servier.

Brussels, Belgium
European Commissioner for Competition Neelie Kroes talking to the press about an investigation of suspected collusion among pharmaceuticals, including Slovenian drug maker Krka.
Photo: Thierry Monasse/STA

Brussels, Belgium
European Commissioner for Competition Neelie Kroes talking to the press about an investigation of suspected collusion among pharmaceuticals, including Slovenian drug maker Krka.
Photo: Thierry Monasse/STA

Brussels, Belgium
European Commissioner for Competition Neelie Kroes talking to the press about an investigation of suspected collusion among pharmaceuticals, including Slovenian drug maker Krka.
Photo: Thierry Monasse/STA

Brussels, Belgium
European Commissioner for Competition Neelie Kroes talking to the press about an investigation of suspected collusion among pharmaceuticals, including Slovenian drug maker Krka.
Photo: Thierry Monasse/STA

The rest of this news item is available to subscribers.
The news item consists of 1.206 characters (without spaces) or 225 words words.

Buy the news item. Price: 2 tokens; on account: 0 tokens.

mas/gj/gj
© STA, 2009